HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Double-blind comparative prospective clinical evaluation of a combination antispasmodic--Manyana (R) (diclofenac pitafenone and fenpeverinium) and Baralgan (analgin + pitafenone and fenpeverinium) in intestinal, biliary and ureteric colic.

AuthorsA Chaudhary, R L Gupta
JournalJournal of the Indian Medical Association (J Indian Med Assoc) Vol. 96 Issue 11 Pg. 359-60 (Nov 1998) ISSN: 0019-5847 [Print] India
PMID10218327 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Benzophenones
  • Drug Combinations
  • Parasympatholytics
  • Piperidines
  • manyana
  • Diclofenac
  • Dipyrone
  • fenpiverinium bromide, pitofenone hydrochloride, dipyrone drug combination
Topics
  • Adolescent
  • Adult
  • Benzophenones (therapeutic use)
  • Biliary Tract Diseases (diagnosis, drug therapy)
  • Colic (diagnosis, drug therapy)
  • Diclofenac (therapeutic use)
  • Dipyrone (therapeutic use)
  • Double-Blind Method
  • Drug Combinations
  • Drug Synergism
  • Drug Therapy, Combination
  • Female
  • Humans
  • Intestinal Diseases (diagnosis, drug therapy)
  • Male
  • Middle Aged
  • Parasympatholytics (therapeutic use)
  • Piperidines (therapeutic use)
  • Prospective Studies
  • Treatment Outcome
  • Ureteral Diseases (diagnosis, drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: